Deciphex
Founded 2017 · 183 employees on LinkedIn · 5 known investors
Deciphex develops AI-based digital pathology platforms for clinical diagnostics and drug development, including Diagnexia for NHS clinical pathology and Patholytix for GLP-compliant preclinical pharma studies. It serves healthcare systems and pharmaceutical companies to speed up pathology reporting and diagnoses.
Investors · 5
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Deciphex do?
- Deciphex develops AI-based digital pathology platforms for clinical diagnostics and drug development, including Diagnexia for NHS clinical pathology and Patholytix for GLP-compliant preclinical pharma studies. It serves healthcare systems and pharmaceutical companies to speed up pathology reporting and diagnoses.
- Who are Deciphex's investors?
- Deciphex's investors include Act Venture Capital, ACT Venture Capital, Claret Capital Partners, Molten Ventures, Seroba Life Sciences.